• Clinical Trials - Myasthenia Gravis (MG)

    Study Objective Contact
    A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects with Refractory Generalized Myasthenia Gravis (gMG) [LCID Study Number: 2014-001] The purpose of this study is to determine if eculizumab is safe and effective for the treatment of refractory generalized Myasthenia Gravis. Principal Investigator(s):
    Doreen T. Ho, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Nick Ventura.